Valeant Pharmaceuticals (NYSE:VRX) wholly owned subsidiary Salix and US WorldMeds announced today that they have entered into an exclusive agreement to co-promote US WorldMeds’ LUCEMYRA™ …
Is Billionaire fund guru Jim Simons switching OPK for VRX?
Valeant Pharmaceuticals (NYSE:VRX) management boiled down its position to BTIG analyst Tim Chiang, where the discussion gravitated on the standing of the company’s …
When quant billionaire David Shaw trades, the world listens. One of the most successful hedge funds of all time, Shaw has now made …
Billionaire Israel “Izzy” Englander, who helmed his fortune from humble, Polish immigrant beginnings took a chance on two giants that have played with …
Valeant Pharmaceuticals (NYSE:VRX) is on the road to redemption after a robust third quarter earnings showcase has seen the company gain around 10% …
